Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
EEDVD-682 by ImmunityBio for Non-Small Cell Lung Cancer: Likelihood of Approval
EEDVD-682 is under clinical development by ImmunityBio and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData,...
EEDVD-682 by ImmunityBio for Kidney Cancer (Renal Cell Cancer): Likelihood of Approval
EEDVD-682 is under clinical development by ImmunityBio and currently in Phase II for Kidney Cancer (Renal Cell Cancer). According to...
EEDVD-682 by ImmunityBio for Solid Tumor: Likelihood of Approval
EEDVD-682 is under clinical development by ImmunityBio and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...
EEDVD-682 by ImmunityBio for Bladder Cancer: Likelihood of Approval
EEDVD-682 is under clinical development by ImmunityBio and currently in Phase II for Bladder Cancer. According to GlobalData, Phase II...
EEDVD-682 by ImmunityBio for Head And Neck Cancer: Likelihood of Approval
EEDVD-682 is under clinical development by ImmunityBio and currently in Phase II for Head And Neck Cancer. According to GlobalData,...
EEDVD-682 by ImmunityBio for Melanoma: Likelihood of Approval
EEDVD-682 is under clinical development by ImmunityBio and currently in Phase II for Melanoma. According to GlobalData, Phase II drugs...
EEDVD-682 by ImmunityBio for Colorectal Cancer: Likelihood of Approval
EEDVD-682 is under clinical development by ImmunityBio and currently in Phase II for Colorectal Cancer. According to GlobalData, Phase II...